Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease
PaperCitations, authors & open-access status
A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 26 citations, 2020 year and hybrid oa status.
26
Citations
2020
Year
hybrid
OA Status